U.S. Dermatology Partners | Dermatology and Skin Cancer Center Leawood

Research site
11550 Granada Lane, Leawood, Kansas, United States of America

Site insights

Top conditions

Top treatments


Parent organization

This site is a part of U.S. Dermatology Partners

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 4 total trials

A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-SHUTTLE)

The coprimary objectives of the study are to:* evaluate the efficacy of rocatinlimab in combination with topical corticosteroid and/or topical calcin...

Active, not recruiting
Atopic Dermatitis
Other: Placebo
Drug: Rocatinlimab

The primary objectives of this study are to:* estimate vaccine response in rocatinlimab group vs placebo group, assessed using antibody anti-tetanus...

Active, not recruiting
Atopic Dermatitis
Moderate-to-severe Atopic Dermatitis
Drug: Placebo
Drug: Rocatinlimab

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.

Atopic Dermatitis
Drug: Rocatinlimab
Other: Placebo

The primary objective of this study is to assess successful self-administration of rocatinlimab subcutaneous using devices for injection at home.

Atopic Dermatitis
Combination Product: Rocatinlimab Prefilled Syringe

Trial sponsors

Amgen logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems